Bexorg

Bexorg is a privately held techbio company with the first-ever full tech stack platform to support CNS drug discovery and development in the human brain in a way that has not been possible before.

Our proprietary whole-brain perfusion technology can be used to study brain connectivity, circuit function, and disease processes, with the aim to identify novel targets, biomarkers, and effectiveness of therapeutics for neurological disorders before going into the clinic.

Our proprietary BrainEx platform generates high-fidelity human brain molecular datasets that drive our XO Digital application, a machine learning and AI-centered engine for drug discovery and development. In collaboration with the NIH, Bexorg’s founders have been at the forefront of bioethics in post-mortem human brain scientific research, and we have an independent board comprised of bioethics leaders to ensure our operations maintain the highest standards.

Bexorg is strategically partnering with leading neuroscience companies to integrate its platform into CNS clinical development programs, as well as advancing in-house neurodegeneration assets.

Watch our video review: Bexorg Review: The AI + Whole-Human Brain Platform Revolutionizing Drug Discovery